Related Experiment Video
Updated: Feb 11, 2026

Characterization of Human Monocyte Subsets by Whole Blood Flow Cytometry Analysis
Published on: October 17, 2018
Circulating monocyte subsets in human chronic graft-versus-host disease
Takaaki Konuma1, Chisato Kohara2, Eri Watanabe3
1Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. tkonuma@ims.u-tokyo.ac.jp.
Insights
Chronic graft-versus-host disease (cGVHD) involves monocytes/macrophages. Specific monocyte subset surface marker alterations correlate with organ-specific cGVHD, suggesting potential biomarkers for this condition after hematopoietic cell transplantation.
Area of Science:
- Immunology
- Hematology
- Transplantation Medicine
Background:
- Chronic graft-versus-host disease (cGVHD) is a significant complication following allogeneic hematopoietic cell transplantation (HCT).
- Monocytes and macrophages are key players in the inflammatory and fibrotic processes characteristic of cGVHD.
- Understanding monocyte subset behavior is crucial for managing cGVHD.
Purpose of the Study:
- To investigate the expression of surface markers on circulating monocyte subsets in patients post-HCT.
- To determine if these marker expressions correlate with the presence and severity of cGVHD.
- To identify potential biomarkers for organ-specific cGVHD.
Main Methods:
- Analysis of monocyte subset populations (classical, non-classical) in 145 patients at least 12 months post-HCT without disease recurrence.
- Measurement of activation markers, chemokine receptors (e.g., CCR5, CX3CR1), and scavenger receptors (e.g., CD204) on monocytes.
- Correlation of marker expression levels with clinical manifestations of cGVHD, including joint and lung involvement.
Main Results:
- No significant differences in monocyte subset numbers or proportions were observed between patients with and without cGVHD.
- Lower CCR5 expression on classical monocytes was associated with joint cGVHD.
- Higher CD204 and lower CX3CR1 expression on non-classical monocytes were linked to lung cGVHD.
Conclusions:
- Alterations in surface markers on circulating monocyte subsets are associated with organ-specific cGVHD development.
- These specific monocyte surface marker changes may serve as candidate biomarkers for cGVHD.
- Further research into these monocyte alterations could lead to improved diagnostics and therapeutics for cGVHD.
Abstract:
Chronic graft-versus-host disease (cGVHD) is a major cause of late morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT). Monocytes/macrophages play a central role in inflammation, tissue repair, and fibrosis, which are the main clinical features of cGVHD. Here, we examined the expression levels of activation markers, chemokine receptors, and scavenger receptors for each circulating monocyte subset in 145 patients without disease recurrence at least 12 months after undergoing allogeneic HCT. There were no significant differences in the numbers and the proportions of each monocyte subset between patients without cGVHD and those with mild or moderate/severe cGVHD. Lower expression of CCR5 on classical monocytes, and higher expression of CD204 and lower expression of CX3CR1 on non-classical monocytes were associated with joint, and lung cGVHD, respectively. These data showed that alterations of activation markers and chemokine and scavenger receptors in each circulating monocyte subset were associated with the development of organ-specific cGVHD. Alterations of surface markers in each circulating monocyte subset may be candidate biomarkers for cGVHD.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Kidney Disease I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Kidney Disease II: Clinical Manifestations

